168 related articles for article (PubMed ID: 11178940)
21. Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets.
Pratico D; Lawson JA; Fitzgerald GA
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():229-31. PubMed ID: 7732840
[No Abstract] [Full Text] [Related]
22. Study of the two pathways for arachidonate oxygenation in blood platelets.
Dutilh CE; Haddeman E; Jouvenaz GH; Ten Hoor F; Nugteren DH
Lipids; 1979 Feb; 14(2):241-6. PubMed ID: 34075
[TBL] [Abstract][Full Text] [Related]
23. 15-hydroxy-5,8,11,13-eicosatetraenoic acid: A potent and selective inhibitor of platelet lipoxygenase.
Vanderhoek JY; Bryant RW; Bailey JM
J Biol Chem; 1980 Jul; 255(13):5996-8. PubMed ID: 6771259
[TBL] [Abstract][Full Text] [Related]
24. Dual inhibition of cyclooxygenase and lipoxygenase by human haptoglobin: its polymorphism and relation to hemoglobin binding.
Saeed SA; Ahmad N; Ahmed S
Biochem Biophys Res Commun; 2007 Feb; 353(4):915-20. PubMed ID: 17198677
[TBL] [Abstract][Full Text] [Related]
25. Monochloramine potently inhibits arachidonic acid metabolism in rat platelets.
Fujimoto Y; Ikeda M; Sakuma S
Biochem Biophys Res Commun; 2006 May; 344(1):140-5. PubMed ID: 16615995
[TBL] [Abstract][Full Text] [Related]
26. Effects of endocrine disruptors on arachidonic acid metabolism in rabbit platelets.
Fujimoto Y; Sakuma S; Nishiwaki Y; Ikeda M; Fujita T
Toxicol Appl Pharmacol; 2003 Jun; 189(2):96-9. PubMed ID: 12781627
[TBL] [Abstract][Full Text] [Related]
27. Perfluorinated carboxylic acids inhibit cyclooxygenase pathway more potently than 12-lipoxygenase pathway in rat platelets.
Sakuma S; Fujii Y; Abe M; Arakawa Y; Fujimoto Y
Prostaglandins Leukot Essent Fatty Acids; 2010; 83(4-6):225-8. PubMed ID: 20678909
[TBL] [Abstract][Full Text] [Related]
28. Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation.
Akiba S; Murata T; Kitatani K; Sato T
Biol Pharm Bull; 2000 Nov; 23(11):1293-7. PubMed ID: 11085354
[TBL] [Abstract][Full Text] [Related]
29. Effects of nonanal, trans-2-nonenal and 4-hydroxy-2,3-trans-nonenal on cyclooxygenase and 12-lipoxygenase metabolism of arachidonic acid in rabbit platelets.
Sakuma S; Fujimoto Y; Tagano S; Tsunomori M; Nishida H; Fujita T
J Pharm Pharmacol; 1997 Feb; 49(2):150-3. PubMed ID: 9055186
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of endogenous arachidonic acid in weakly activated platelets. Absence of leukocyte cooperative products in whole blood.
Guichardant M; Petit F; Lagarde M
Eicosanoids; 1989; 2(2):117-21. PubMed ID: 2516743
[TBL] [Abstract][Full Text] [Related]
31. High density lipoprotein inhibits platelet 12-lipoxygenase activity.
Fujimoto Y; Tsunomori M; Muta E; Yamamoto T; Nishida H; Sakuma S; Fujita T
Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):355-8. PubMed ID: 7827811
[TBL] [Abstract][Full Text] [Related]
32. Enzyme immunoassays for cyclooxygenase and 12-lipoxygenase of human platelets.
Yoshimoto T; Ehara H; Konishi Y; Yokoyama C; Murakami J; Yamamoto S; Hattori A
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():82-5. PubMed ID: 2526567
[No Abstract] [Full Text] [Related]
33. Rapid inactivation of cyclooxygenase activity after stimulation of intact platelets.
Lapetina EG; Cuatrecasas P
Proc Natl Acad Sci U S A; 1979 Jan; 76(1):121-5. PubMed ID: 218191
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of 8,11,14,17-eicosatetraenoic acid by human platelet lipoxygenase and cyclooxygenase.
Careaga MM; Sprecher H
Biochim Biophys Acta; 1987 Jul; 920(1):94-101. PubMed ID: 3109494
[TBL] [Abstract][Full Text] [Related]
35. Isomers of trans fatty acids modify the activity of platelet 12-P lipoxygenase and cyclooxygenase/thromboxane synthase.
Stachowska E; DoĊegowska B; Olszewska M; Gutowska I; Chlubek D
Nutrition; 2004 Jun; 20(6):570-1. PubMed ID: 15165621
[TBL] [Abstract][Full Text] [Related]
36. Sphingomyelin inhibits platelet 12-lipoxygenase activity.
Fujimoto Y; Sakuma S; Tsunomori M; Sumiya T; Fujita T
Eur J Pharmacol; 1999 Aug; 378(2):233-6. PubMed ID: 10478636
[TBL] [Abstract][Full Text] [Related]
37. Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes.
Smith JB; Dangelmaier C; Mauco G
Biochim Biophys Acta; 1985 Jul; 835(2):344-51. PubMed ID: 3924113
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of platelet lipoxygenase by esculetin.
Sekiya K; Okuda H; Arichi S
Biochim Biophys Acta; 1982 Oct; 713(1):68-72. PubMed ID: 6814494
[TBL] [Abstract][Full Text] [Related]
39. Anti-platelet activity of diacetylated obovatol through regulating cyclooxygenase and lipoxygenase activities.
Yu JY; Lee JJ; Jung JK; Min YK; Ma JY; Kim TJ; Lee MY; Yun YP
Arch Pharm Res; 2012 Dec; 35(12):2191-8. PubMed ID: 23263814
[TBL] [Abstract][Full Text] [Related]
40. Irreversible platelet aggregation does not depend on lipoxygenase metabolites.
Rao GH; Radha E; White JG
Biochem Biophys Res Commun; 1985 Aug; 131(1):50-7. PubMed ID: 3929780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
